Esperion CEO Sheldon Koenig sells shares worth over $26k By Investing.com
Sheldon L. Koenig, CEO of Esperion Therapeutics, Inc. (NASDAQ:ESPR), sold a total of 14,550 shares of the company's common stock. The transaction, which occurred on September 17, 2024, was executed at a price of $1.796 per share, resulting…
